On January 23, 2017, PURE Bioscience, Inc. (OTCPK:PURE) closed the transaction. The company has issued 396,496 units for gross proceeds of $337,021.6 in the second tranche. The company received net proceeds of $307,000 in second tranche. The company has received gross proceeds of $1,337,022.6 and approximately net proceeds of $1,082,000 in the transaction. The transaction included participation from five investors.